Exxel Pharma Inc. (EXXL)

Exxel Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	0.37	0.44	0.24
Cash & Cash Equivalents	0.37	0.44	0.24
Cash Growth	-	85.76%	-
Other Current Assets	0.01	0.06	0.06
Total Current Assets	0.38	0.51	0.3
Total Assets	-	0.51	0.3
Accounts Payable	-	0.22	0.29
Current Debt	-	0.51	-
Other Current Liabilities	2.57	0.91	0.87
Total Current Liabilities	2.57	1.65	1.16
Total Liabilities	-	1.65	1.16
Total Debt	1.41	0.51	0
Retained Earnings	-	-4.01	-3.6
Comprehensive Income	-	-0.05	-0.04
Shareholders' Equity	-2.19	-1.15	-0.86
Net Cash (Debt)	-1.05	-0.07	0.24
Working Capital	-2.19	-1.15	-0.86

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).